Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hollow Mesoporous Prussian Blue Nanoparticles for in Vivo Synergistic Chemo-Photothermal Cancer Therapy and Dual-Mode Magnetic Resonance/Fluorescence Imaging Publisher



Daneshi M1 ; Farahbakhsh Z2, 3 ; Mehrgardi MA1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, University of Isfahan, Isfahan, 81746-73441, Iran
  2. 2. Department of Medical Parasitology and Mycology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  3. 3. Biosensor Research Center (BRC), Isfahan University of Medical Sciences (IUMS), Isfahan, 81746-73461, Iran

Source: ACS Applied Nano Materials Published:2024


Abstract

The development of a theranostic platform that integrates multiple modalities into a single entity is a hopeful approach for effective cancer treatment but still a challenge. This study presents a smart and versatile theranostic nanoplatform for remarkably potent in vivo synergistic chemo-photothermal tumor treatment, guided by MR/fluorescence dual-mode imaging utilizing a pH-responsive strategy. We encapsulated Gd3+-based carbon quantum dots (GCDs) and doxorubicin (DOX) within hollow mesoporous Prussian blue nanoparticles (HMPB NPs). This innovative theranostic platform, named DOX/GCDs-HMPB NPs, facilitates targeted drug release and simultaneous MR/fluorescence imaging, specifically at the tumor site. At physiological pH, both GCDs and DOX molecules are encapsulated within the mesoporous hollow network of the nanoparticles, with the metal-ligand coordination bonding between Gd species and DOX molecules, to restrict water molecules’ access to the Gd3+ center, thus minimizing proton relaxivity. In the acidic tumor microenvironment, GCDs and DOX drug molecules are released simultaneously from the nanoparticles and enhance both MR contrast and fluorescence, leading to an increase in chemotherapeutic activities. This system reveals strong pH-switching theranostic performance for 4T1 cells, with high-efficiency chemotherapy and considerable photothermal conversion, indicating practical application for synergistic chemo-photothermal treatment of tumors. A promising strategy for developing a theranostic platform for cancer treatment and diagnosis is introduced. © 2024 American Chemical Society
Experts (# of related papers)
Other Related Docs
17. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
18. Mxenes in Photomedicine: Advances and Prospects, Chemical Communications (2022)
19. Recent Progress in Cancer Immunotherapy: Application of Nano-Therapeutic Systems, Journal of Drug Delivery Science and Technology (2024)
24. Mxenes for Cancer Therapy and Diagnosis: Recent Advances and Current Challenges, ACS Biomaterials Science and Engineering (2021)
28. Advanced Nanosystems for Cancer Therapeutics: A Review, ACS Applied Nano Materials (2023)
46. A Literature Review on Multimodality Molecular Imaging Nanoprobes for Cancer Detection, Polish Journal of Medical Physics and Engineering (2019)
48. Functionalized Magnetic Nanoparticles for Cancer Therapy, Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices (2024)